Your browser doesn't support javascript.
loading
Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS-001 clinical trial.
Hernando-Calvo, Alberto; Malone, Eoghan; Day, Daphne; Prawira, Amy; Weinreb, Ilan; Yang, S Y Cindy; Wong, Horace; Rodriguez, Angela; Jennings, Sarah; Eliason, Anneli; Wang, Lisa; Spreafico, Anna; Siu, Lillian L; Hansen, Aaron R.
Affiliation
  • Hernando-Calvo A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre. Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Malone E; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre. Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Day D; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre. Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Prawira A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre. Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Weinreb I; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Yang SYC; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Wong H; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Rodriguez A; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Jennings S; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Eliason A; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Wang L; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Spreafico A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre. Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre. Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Hansen AR; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre. Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Cancer Med ; 12(20): 20299-20310, 2023 10.
Article in En | MEDLINE | ID: mdl-37818869
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salivary Gland Neoplasms / Carcinoma, Acinar Cell Type of study: Guideline / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Med Year: 2023 Type: Article Affiliation country: Canada
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salivary Gland Neoplasms / Carcinoma, Acinar Cell Type of study: Guideline / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Med Year: 2023 Type: Article Affiliation country: Canada